Differential evaluation of hepatocyte apoptosis and necrosis in acute liver injury

Hepatology Research

Volumn 40, Issue 6, 2010, Pages 605-612

  Onodera, Mio ^a   Takikawa, Yasuhiro ^a   Kakisaka, Keisuke ^a   Wang, Ting ^a   Horiuchi, Saburo ^b  

^a Division of Gastroenterology and Hepatology   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cytokelatin 18; HMGB 1; Oncotic necrosis

Indexed keywords

AMINOTRANSFERASE; CASPASE 3; CYTOKERATIN 18; HIGH MOBILITY GROUP B1 PROTEIN; HYDROGEN PEROXIDE; STAUROSPORINE;

ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL DEATH; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; EPSTEIN BARR VIRUS INFECTION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIVER CELL; LIVER INJURY; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 77954355705     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00648.x     Document Type: Article

References (23)

1. Muto Y. Present status of fulminant hepatitis in Japan. Gastroenterol Jpn 1993, 28(4):120-7. Suppl
2. Mori M, Itanai F, Washio S. Estimated number of patients with intractable diseases in Japan based on nationwide epidemiology surveillance. 2006, 39-42. Annual Report of Epidemiology Research for Intractable Diseases in Japan, the Ministry of Health, Welfare and Labor (2005, In Japanese
3. Sato S, Suzuki K, Takikawa Y. Clinical Epidemiology of Fulminant Hepatitis in Japan before the Substantial Introduction of Liver Transplantation: an Analysis of 1309 Cases in a 15-Year National Survey. Hepatol Res 2004, 30:155-61.
4. Fujiwara K, Mochida S, Matsui A. Summary of 698 patients between 1998 and 2003 analyzed by the annual national survey. Hepatol Res 2008, 38:646-57.
5. Takikawa Y, Suzuki K. Clinical epidemiology of fulminant hepatitis in Japan. Hepatol Res 2008, 38(1):S14-18. Suppl
6. Heathcote J, Elewaut A, Fedail S. OMGE practice guideline. Management of acute viral hepatitis. World Gastroenterol News 2004, 9:1-12. Suppl
7. Dufour DR, Lott JA, Nolte FS. Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clin Chem 2000, 46:2050-68.
8. Lee WM. Acute liver failure. N Engl J Med 1993, 329:1862-72.
9. Sainokami S, Abe K, Sato A. Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection. J Gastroenterol 2007, 42:241-9.
10. Muto Y, Nouri-Aria KT, Meager A. Enhanced tumor necrosis factor and interleukin-1 in fulmiant hepatic failure. Lancet 1988, 2:72-4.
11. Nagaki M, Naiki T, Brenner DA. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology 2000, 32:1272-9.
12. Yasumi Y, Takikawa Y, Endo R. Interleukin-17 as new marker of severity of acute hepatic injury. Hepatol Res 2007, 37:248-54.
13. Rake MO, Flute PT, Pannel G. Intravascular coagulation in acute hepatic necrosis. Lancet 1970, 1:533-7.
14. Malhi H, Gores JG, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006, 43:S31-44.
15. Chisari FV. Virus, immunity, and cancer: lessons from hepatitis B. Am J Pathol 2000, 156:1118-32.
16. Bantel H, Lugering A, Heidemann J. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004, 40:1078-87.
17. Feldstein AE, Gores GJ. An apoptosis biomarker goes to the HCV clinic. Hepatology 2004, 40:1044-6.
18. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-5.
19. Takikawa Y, Endo R, Suzuki K. Prediction of hepatic encephalopathy development in patients with severe acute hepatitis. Dig Dis Sci 2006, 51:359-64.
20. Shibayama Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol 1987, 151:315-21.
21. Mochida S, Arai M, Ohno A. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999, 29:1532-40.
22. Rake MO, Flute PT, Pannell G. Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen. Gut 1973, 14:574-80.
23. Takikawa Y, Endo R, Suzuki K. Early prediction of short-term development of hepatic encephalopathy in patients with acute liver disease unrelated to paracetamol. A prospective study in Japan. J Hepatol 2009, 51:1021-9.